glutathione s-transferase gst pull-down assay (GST) and Co-immunoprecipitation The role of glutathione-S-transferase in

This antioxidant has been associated with a delay in the clinical onset of the disease (Table 1) in transgenic mice that express mutant copies of the gene encoding SOD1 (an animal model of ALS) (Gurney et al., 1996)

Glutathione IV therapy allows the primary antioxidant to combat the bodys oxidative stress

This increase in 2,3-DPG levels may be related to respiratory alkalosis, hormone effects and relative anaemia during pregnancy (Reference Bille-brahe and Rorth119)

While the risk at therapeutic doses remains low, reduced liver synthetic function or impaired metabolic pathways may warrant closer monitoring and dose adjustment